Yoon-Jin Lee1, Soo A Kim2, Sang-Han Lee1. 1. Department of Biochemistry, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan 330-721, Korea. 2. Department of Physical Medicine and Rehabilitation, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan 330-721, Korea.
Abstract
AIM: Intra-articular injection of local anesthetics (LAs) is a common procedure for therapeutic purposes. However, LAs have been found toxic to articular cartilage, and hyaluronan may attenuate this toxicity. In this study we investigated whether hyaluronan attenuated lidocaine-induced chondrotoxicity, and if so, to elucidate the underlying mechanisms. METHODS: Human chondrocyte cell line SW1353 and newly isolated murine chondrocytes were incubated in culture medium containing hyaluronan and/or lidocaine for 72 h. Cell viability was evaluated using MTT assay. Cell apoptosis was detected with DAPI staining, caspase 3/7 activity assay and flow cytometry. Cell cycle distributions, ROS levels and mitochondrial membrane potential (ΔΨm) were determined using flow cytometry. The expression of p53 and p53-regulated gene products was measured with Western blotting. RESULTS: Lidocaine (0.005%-0.03%) dose-dependently decreased the viability of SW1353 cells. This local anesthetic (0.015%, 0.025%) induced apoptosis, G2/M phase arrest and loss of ΔΨm, and markedly increased ROS production in SW1353 cells. Hyaluronan (50-800 μg/mL) alone did not affect the cell viability, but co-treatment with hyaluronan (200 μg/mL) significantly attenuated lidocaine-induced apoptosis and other abnormalities in SW1353 cells. Furthermore, co-treatment with lidocaine and hyaluronan significantly decreased the levels of p53 and its transcription targets Bax and p21 in SW1353 cells, although treatment with lidocaine alone did not significantly change these proteins. Similar results were obtained in ex vivo cultured murine chondrocytes. CONCLUSION: Hyaluronan suppresses lidocaine-induced apoptosis of human chondrocytes in vitro through inhibiting the p53-dependent mitochondrial apoptotic pathway.
AIM: Intra-articular injection of local anesthetics (LAs) is a common procedure for therapeutic purposes. However, LAs have been found toxic to articular cartilage, and hyaluronan may attenuate this toxicity. In this study we investigated whether hyaluronan attenuated lidocaine-induced chondrotoxicity, and if so, to elucidate the underlying mechanisms. METHODS:Human chondrocyte cell line SW1353 and newly isolated murine chondrocytes were incubated in culture medium containing hyaluronan and/or lidocaine for 72 h. Cell viability was evaluated using MTT assay. Cell apoptosis was detected with DAPI staining, caspase 3/7 activity assay and flow cytometry. Cell cycle distributions, ROS levels and mitochondrial membrane potential (ΔΨm) were determined using flow cytometry. The expression of p53 and p53-regulated gene products was measured with Western blotting. RESULTS:Lidocaine (0.005%-0.03%) dose-dependently decreased the viability of SW1353 cells. This local anesthetic (0.015%, 0.025%) induced apoptosis, G2/M phase arrest and loss of ΔΨm, and markedly increased ROS production in SW1353 cells. Hyaluronan (50-800 μg/mL) alone did not affect the cell viability, but co-treatment with hyaluronan (200 μg/mL) significantly attenuated lidocaine-induced apoptosis and other abnormalities in SW1353 cells. Furthermore, co-treatment with lidocaine and hyaluronan significantly decreased the levels of p53 and its transcription targets Bax and p21 in SW1353 cells, although treatment with lidocaine alone did not significantly change these proteins. Similar results were obtained in ex vivo cultured murine chondrocytes. CONCLUSION:Hyaluronan suppresses lidocaine-induced apoptosis of human chondrocytes in vitro through inhibiting the p53-dependent mitochondrial apoptotic pathway.
Authors: Brinda Ravikumar; Sovan Sarkar; Janet E Davies; Marie Futter; Moises Garcia-Arencibia; Zeyn W Green-Thompson; Maria Jimenez-Sanchez; Viktor I Korolchuk; Maike Lichtenberg; Shouqing Luo; Dunecan C O Massey; Fiona M Menzies; Kevin Moreau; Usha Narayanan; Maurizio Renna; Farah H Siddiqi; Benjamin R Underwood; Ashley R Winslow; David C Rubinsztein Journal: Physiol Rev Date: 2010-10 Impact factor: 37.312
Authors: Valentina Grishko; Min Xu; Renee Ho; Aaron Mates; Scott Watson; Jong T Kim; Glenn L Wilson; Albert W Pearsall Journal: J Biol Chem Date: 2009-02-04 Impact factor: 5.157
Authors: Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Giuseppe Mandraffino; Alberto Calatroni; Antonino Saitta; Salvatore Campo; Giuseppe M Campo Journal: Inflamm Res Date: 2017-08-12 Impact factor: 4.575
Authors: P Busse; C Vater; M Stiehler; J Nowotny; P Kasten; H Bretschneider; S B Goodman; M Gelinsky; S Zwingenberger Journal: Bone Joint Res Date: 2019-03-02 Impact factor: 5.853